Omeros stock rises after a $340 million deal with Novo Nordisk. Learn about its improved risk profile and covered call trade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback